Analysis of Retracted Publications in the Diabetes Literature.

Q2 Medicine
Medical Journal of the Islamic Republic of Iran Pub Date : 2026-02-28 eCollection Date: 2026-01-01 DOI:10.47176/mjiri.40.20
Somayeh Parvin, Mahshid Lotfi, Mohsen Nouri
{"title":"Analysis of Retracted Publications in the Diabetes Literature.","authors":"Somayeh Parvin, Mahshid Lotfi, Mohsen Nouri","doi":"10.47176/mjiri.40.20","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Retraction serves as a critical corrective mechanism in scientific publishing, preventing the spread of flawed or misleading data. This study aimed to systematically analyze the characteristics of retracted articles within the field of diabetes research, highlight potential vulnerabilities in the integrity of diabetes research, and address gaps in understanding the nature and implications of research misconduct in this crucial medical discipline.</p><p><strong>Methods: </strong>This study aimed to analyze retracted publications in the field of diabetes published from 1978 to 2024 using the Web of Science database. Information from the selected articles was obtained through the Retraction Watch Database. Extracted details included the journal title, type of article, country of origin, publication and retraction dates, number of authors, and reasons for retraction. The collected data were analyzed using descriptive statistical methods.</p><p><strong>Results: </strong>Between 1978 and 2024, our review revealed 316 retracted articles. The journals Science (n = 1517) and The Lancet (n = 742) accounted for the highest number of these highly cited retractions, while the journals Biomed Research International (n = 31) and Diabetes (n = 15) accounted for the most cited of these retractions. The most common reasons for retraction were investigations initiated by the journal or publisher and concerns related to data integrity. The years with the highest number of retractions were 2023 (n = 91) and 2016 (n = 40), whereas the majority of retracted articles were initially published in 2022 and 2021 (n = 26). Collaborative research involving authors from China (n = 137), the United States (n = 71), and India (n = 24) was most frequently associated with these retractions.</p><p><strong>Conclusion: </strong>Safeguarding the integrity of scientific literature, particularly in high-stakes fields such as diabetes research, requires a fundamental shift from reactive retractions to multilateral proactive systemic reform. Cultivating an ethical research culture (changing incentives to reward research quality and transparency over quantity by Institutions and funders); empowering researchers (providing the skills for rigorous and ethical research through mandatory, ongoing ethics training); and ensuring vigilant publishing (enforcing clear policies, rapidly investigating issues, and performing transparent retractions to protect the scientific record by journals).</p>","PeriodicalId":18361,"journal":{"name":"Medical Journal of the Islamic Republic of Iran","volume":"40 ","pages":"20"},"PeriodicalIF":0.0000,"publicationDate":"2026-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13404472/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of the Islamic Republic of Iran","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47176/mjiri.40.20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Retraction serves as a critical corrective mechanism in scientific publishing, preventing the spread of flawed or misleading data. This study aimed to systematically analyze the characteristics of retracted articles within the field of diabetes research, highlight potential vulnerabilities in the integrity of diabetes research, and address gaps in understanding the nature and implications of research misconduct in this crucial medical discipline.

Methods: This study aimed to analyze retracted publications in the field of diabetes published from 1978 to 2024 using the Web of Science database. Information from the selected articles was obtained through the Retraction Watch Database. Extracted details included the journal title, type of article, country of origin, publication and retraction dates, number of authors, and reasons for retraction. The collected data were analyzed using descriptive statistical methods.

Results: Between 1978 and 2024, our review revealed 316 retracted articles. The journals Science (n = 1517) and The Lancet (n = 742) accounted for the highest number of these highly cited retractions, while the journals Biomed Research International (n = 31) and Diabetes (n = 15) accounted for the most cited of these retractions. The most common reasons for retraction were investigations initiated by the journal or publisher and concerns related to data integrity. The years with the highest number of retractions were 2023 (n = 91) and 2016 (n = 40), whereas the majority of retracted articles were initially published in 2022 and 2021 (n = 26). Collaborative research involving authors from China (n = 137), the United States (n = 71), and India (n = 24) was most frequently associated with these retractions.

Conclusion: Safeguarding the integrity of scientific literature, particularly in high-stakes fields such as diabetes research, requires a fundamental shift from reactive retractions to multilateral proactive systemic reform. Cultivating an ethical research culture (changing incentives to reward research quality and transparency over quantity by Institutions and funders); empowering researchers (providing the skills for rigorous and ethical research through mandatory, ongoing ethics training); and ensuring vigilant publishing (enforcing clear policies, rapidly investigating issues, and performing transparent retractions to protect the scientific record by journals).

糖尿病文献中撤回出版物分析。
背景:撤稿是科学出版中重要的纠正机制,可以防止有缺陷或误导性数据的传播。本研究旨在系统分析糖尿病研究领域撤回文章的特征,强调糖尿病研究完整性的潜在脆弱性,并解决在理解这一重要医学学科研究不端行为的性质和影响方面的差距。方法:本研究旨在分析Web of Science数据库1978 - 2024年间发表的糖尿病领域的撤稿论文。所选文章的信息通过撤稿观察数据库获得。提取的详细信息包括期刊名称、文章类型、原产国、出版和撤稿日期、作者人数和撤稿原因。收集的资料采用描述性统计方法进行分析。结果:1978年至2024年间,我们的综述发现了316篇撤稿文章。《科学》(n = 1517)和《柳叶刀》(n = 742)期刊的撤稿次数最多,而《Biomed Research International》(n = 31)和《糖尿病》(n = 15)期刊的撤稿次数最多。撤稿最常见的原因是期刊或出版商发起的调查,以及对数据完整性的担忧。撤稿数量最多的年份是2023年(n = 91)和2016年(n = 40),而大多数撤稿文章最初发表于2022年和2021年(n = 26)。来自中国(n = 137)、美国(n = 71)和印度(n = 24)作者的合作研究最常与这些撤稿相关。结论:维护科学文献的完整性,特别是在糖尿病研究等高风险领域,需要从被动撤回到多边主动系统改革的根本性转变。培养合乎道德的研究文化(改变激励机制,以奖励研究质量和透明度,而不是数量);赋予研究人员权力(通过强制性的、持续的伦理培训,为严格和合乎伦理的研究提供技能);确保警惕的出版(执行明确的政策,迅速调查问题,执行透明的撤稿以保护期刊的科学记录)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
90
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书